NASDAQ:ABCL

Abcellera Biologics Stock Insider Trading

Healthcare > Biotechnology

Buy ABCL

*Your capital is at risk

$5.72

-0.410 (-6.69%)

At Close: Jun 03, 2026

AbCellera Biologics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 30.8M and sold 1.22M ABCL shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	30.8M shares
● Sell	1.22M shares
95% Buy Activity Negligible or No Correlation
Buy Signal High Confidence Jan 02, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 100. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (95% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
May 14, 2026 Buy	Common Shares P-Purchase	Montalbano John S. Director	Director	20 000 Value: $95.4K
Feb 27, 2026 Buy	Common Shares P-Purchase	Thermopylae Holdings Ltd. 10 Percent Owner	10% Owner	38 000 Value: $130.7K
Feb 27, 2026 Buy	Common Shares P-Purchase	Booth Andrew Chief Financial Officer	C-Suite Officer	42 600 Value: $145.7K
Feb 26, 2026 Buy	Common Shares P-Purchase	Thermopylae Holdings Ltd. 10 Percent Owner	10% Owner	177 457 Value: $580.3K
Jan 01, 2026 Buy	Share option (right to buy) A-Award	Lecault Veronique Chief Technology Officer	Officer	539 265 Value: $1.84M
Jan 01, 2026 Buy	Share option (right to buy) A-Award	Stimart Tryn Chief Legal Officer	Officer	539 265 Value: $1.84M
Jan 01, 2026 Buy	Share option (right to buy) A-Award	Hansen Carl L. G. Chief Executive Officer	CEO / President	2 106 505 Value: $7.20M
Jan 01, 2026 Buy	Share option (right to buy) A-Award	Booth Andrew Chief Financial Officer	C-Suite Officer	808 898 Value: $2.77M
Dec 18, 2025 Sell	Common Shares G-Gift	Thermopylae Holdings Ltd. 10 Percent Owner	10% Owner	225 000 Value: $0
Dec 01, 2025 Buy	Share option (right to buy) A-Award	Quake Stephen Director	Director	194 932 Value: $676.4K
Nov 26, 2025 Buy	Common Shares P-Purchase	Montalbano John S. Director	Director	50 000 Value: $178.5K
Nov 10, 2025 Buy	Common Shares	Quake Stephen Director	Director	0 Value: $0
Nov 10, 2025 Buy	Common Shares	Quake Stephen Director	Director	0 Value: $0
Nov 10, 2025 Buy	Common Shares	Quake Stephen Director	Director	0 Value: $0
Jun 12, 2025 Buy	Share option (right to buy) A-Award	Hayden Michael R Director	Director	238 864 Value: $752.4K
Jun 12, 2025 Buy	Share option (right to buy) A-Award	Hayden Michael R Director	Director	238 864 Value: $752.4K
Jun 12, 2025 Buy	Share option (right to buy) A-Award	Lo Andrew Director	Director	238 864 Value: $752.4K
Jun 12, 2025 Buy	Share option (right to buy) A-Award	Montalbano John S. Director	Director	238 864 Value: $752.4K
Jun 12, 2025 Buy	Share option (right to buy) A-Award	Lo Andrew Director	Director	238 864 Value: $752.4K
Jun 12, 2025 Buy	Share option (right to buy) A-Award	Montalbano John S. Director	Director	238 864 Value: $752.4K
Mar 11, 2025 Buy	Common Shares P-Purchase	Thermopylae Holdings Ltd. 10 Percent Owner	10% Owner	343 631 Value: $742.2K
Mar 11, 2025 Buy	Common Shares P-Purchase	Thermopylae Holdings Ltd. 10 Percent Owner	10% Owner	343 631 Value: $742.2K
Mar 10, 2025 Buy	Common Shares P-Purchase	Montalbano John S. Director	Director	25 000 Value: $57.5K
Mar 10, 2025 Buy	Common Shares P-Purchase	Montalbano John S. Director	Director	25 000 Value: $57.5K
Mar 06, 2025 Buy	Common Shares P-Purchase	Montalbano John S. Director	Director	60 000 Value: $140.6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ABCELLERA BIOLOGICS INC.

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and...

Read Full Profile Here